USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CorInnova Incorporated
City: Houston
State: TX
Zip+4: 77030-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (979) 574-0746

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $248,233.00 2
STTR Phase I $99,998.00 1
STTR Phase II $725,068.00 1

Award List:

Proactive Modulation of Strain for Ventricular Recovery

Award Year / Program / Phase: 2005 / STTR / Phase I
Agency: HHS
Research Institution: TEXAS A&M
Principal Investigator: Theresa W. Fossum
Award Amount: $99,998.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a debilitating condition that afflicts nearly 5 million Americans, and it has an increasing incidence. Despite improvements and enormous research efforts (both federally and commercially), pharmacological treatments are… More

Proactive Modulation of Strain for Ventricular Recovery

Award Year / Program / Phase: 2006 / STTR / Phase II
Agency: HHS
Research Institution: Texas A&M
Principal Investigator: Theresa W. Fossum
Award Amount: $725,068.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a debilitating condition that afflicts nearly 5 million Americans, and it has an increasing incidence. Despite improvements and enormous research efforts (both federally and commercially), pharmacological treatments are… More

SBIR Phase I: Pre-clinical Development of Device to Guide Heart Recovery via Assist and Support

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: NSF
Principal Investigator: Michael R. Moreno, MS
Award Amount: $100,000.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project is focused on a novel therapy for heart failure that employs device mediated intervention to guide cardiac growth, remodeling, and recovery. The CorInnova device is the first to combine active cardiac assist and passive cardiac support.… More

Development of a Hybrid Dynamic Stent

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Christina Bolch – 979-220-3117
Award Amount: $148,233.00
Abstract:
DESCRIPTION (provided by applicant): Though drug-eluting stents have successfully reduced restenosis rates in coronary applications, they have not proven as effective in peripheral applications. There is evidence that suggests that restenosis is driven bymechanical factors and that stent placement… More